SciELO - Scientific Electronic Library Online

vol.80 issue4Time to focus child survival programmes on the newborn: assessment of levels and causes of infant mortality in rural Pakistan author indexsubject indexarticles search
Home Page  

Services on Demand




Related links


Bulletin of the World Health Organization

Print version ISSN 0042-9686


HINMAN, Alan R.; IRONS, Beryl; LEWIS, Merle  and  KANDOLA, Kami. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ [online]. 2002, vol.80, n.4, pp.264-270. ISSN 0042-9686.

OBJECTIVE: To investigate whether the incorporation of rubella vaccine into immunization programmes in developing countries is economically justified. METHODS: A MEDLINE search was conducted for articles published between 1970 and 2000 that dealt with economic analyses of rubella and rubella-containing vaccines. The Eastern Mediterranean, South-East Asia, and Africa regional Index Medicus databases and the LILACS database for Latin America and the Caribbean were also searched. FINDINGS: For developed countries, five cost- benefit analyses of rubella vaccine and five of measles-mumps-rubella vaccine as well as two cost-effectiveness analyses were found. For developing countries, five cost analyses and five cost-benefit analyses were found. All the cost-benefit analyses had a benefit:cost ratio greater than 1 and the cost-effectiveness studies indicated that rubella immunization was a cost-effective means of reducing the impact of congenital rubella syndrome. However, the methodologies were not standardized. CONCLUSION: The data support the inclusion of rubella vaccine in the immunization programmes of both developing and developed countries and indicate economic benefits comparable to those associated with hepatitis B vaccine and Haemophilus influenzae type b vaccine. More studies should be carried out on costs for care and immunization using standardized methodologies and locally obtained information.

Keywords : Rubella syndrome; Congenital [prevention and control]; Rubella vaccine [economics]; Measles-mumps-rubella vaccine [economics]; Immunization programs; Developed countries; Países en desarrollo; Cost-benefit analysis; Review literature.

        · abstract in French | Spanish     · text in English     · English ( pdf )